文献速递关节外科运动医学

反向全肩关节置换术使用小梁金属肩胛盂基板至少五年结果

Minimum five-year outcomes of reverse total shoulder arthroplasty using a trabecular metal glenoid base plate.
PubMed 文献 · Bone Joint J · 2021-01-01

单中心回顾性分析190肩(168例)因肩袖关节病或骨关节炎伴肩袖功能不全行小梁金属(TM)背衬肩胛盂假体反向全肩关节置换术(RTSA),平均随访7.27年,7年无翻修生存率94.8%,无无菌性肩胛盂松动生存率95.9%,至少五年临床与影像学结果满意。

要点

  • TM背衬肩胛盂RTSA七年全因翻修生存率94.8%,无菌性肩胛盂松动生存率95.9%。
  • 至少五年随访中位牛津肩评分38分,Constant-Murley评分60分,前屈115°。
  • 肩胛盂切迹见于63.2%的肩关节。

核心结论

  • TM背衬肩胛盂RTSA七年全因翻修生存率94.8%,针对肩胛盂松动的生存率95.9%,至少五年临床与影像学结果满意。

研究设计与样本

  • 单中心回顾性队列,纳入2008年11月至2014年10月连续择期RTSA,适应症为肩袖关节病或骨关节炎伴肩袖功能不全,共190肩(168例,41男127女),平均随访7.27年(SD 1.4)。

主要发现

  • 10肩(5.2%)接受翻修,翻修中位时间21.2个月(IQR 9.9至41.8)。
  • 七年Kaplan-Meier生存率:无菌性肩胛盂机械失败95.9%(95%CI 91.7至98;35肩RTSA at risk),全因翻修94.8%(95%CI 77.5至96.3;35肩RTSA at risk)。
  • 至少五年临床与影像学结果分别有103肩和98肩可用,中位随访6年(IQR 5.2至7.0)。
  • 术后中位牛津肩评分38(IQR 31至45),Constant-Murley评分60(IQR 47.5至70),前屈115°(IQR 100°至125°),外展95°(IQR 80°至120°),外旋25°(IQR 15°至40°)。
  • 肩胛盂切迹见于62肩(63.2%)。

临床怎么用

  • 对于肩袖关节病或骨关节炎伴肩袖功能不全患者,TM背衬肩胛盂RTSA可提供良好的七年假体生存率和至少五年功能改善。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Reverse total shoulder arthroplasty (RTSA) using trabecular metal (TM)-backed glenoid implants has been introduced with the aim to increase implant survival. Only short-term reports on the outcomes of TM-RTSA have been published to date. We aim to present the seven-year survival of TM-backed glenoid implants along with minimum five-year clinical and radiological outcomes. METHODS: All consecutive elective RTSAs performed at a single centre between November 2008 and October 2014 were reviewed. Patients who had primary TM-RTSA for rotator cuff arthropathy and osteoarthritis with deficient cuff were included. A total of 190 shoulders in 168 patients (41 male, 127 female) were identified for inclusion at a mean of 7.27 years (SD 1.4) from surgery. The primary outcome was survival of the implant with all-cause revision and aseptic glenoid loosening as endpoints. Secondary outcomes were clinical, radiological, and patient-related outcomes with a five-year minimum follow-up. RESULTS: The implant was revised in ten shoulders (5.2%) with a median time to revision of 21.2 months (interquartile range (IQR) 9.9 to 41.8). The Kaplan-Meier survivorship estimate at seven years was 95.9% (95% confidence interval (CI) 91.7 to 98; 35 RTSAs at risk) for aseptic mechanical failure of the glenoid and 94.8% (95% CI 77.5 to 96.3; 35 RTSAs at risk) for all-cause revision. Minimum five-year clinical and radiological outcomes were available for 103 and 98 RTSAs respectively with a median follow-up time of six years (IQR 5.2 to 7.0). Median postoperative Oxford Shoulder Score was 38 (IQR 31 to 45); median Constant and Murley score was 60 (IQR 47.5 to 70); median forward flexion 115° (IQR 100° to 125°); median abduction 95° (IQR 80° to 120°); and external rotation 25° (IQR 15° to 40°) Scapular notching was seen in 62 RTSAs (63.2%). CONCLUSION: We present the largest and longest-term series of TM-backed glenoid implants demonstrating 94.8% all-cause survivorship at seven years. Specifically pertaining to glenoid loosening, survival of the implant increased to 95.9%. In addition, we report satisfactory minimum five-year clinical and radiological outcomes. Cite this article: Bone Joint J 2021;103-B(8):1333-1338.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Kankanalu P, Borton ZM, Morgan ML, et al. Minimum five-year outcomes of reverse total shoulder arthroplasty using a trabecular metal glenoid base plate. Bone Joint J. 2021. PMID: 34334038. doi:10.1302/0301-620X.103B8.BJJ-2020-2362.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。